Recombinant Human DNase I Reduces the Viscosity of Cystic Fibrosis Sputum

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1990 Dec 1

PMID 2251263

Citations 190

Authors

S Shak

D J Capon

R Hellmiss

S A Marsters

C L BAKER

Affiliations

Soon will be listed here.

Abstract

Respiratory distress and progressive lung destruction in cystic fibrosis can be attributed to bacterial persistence and the accumulation of viscous purulent secretions in the airways. More than 30 yr ago it was suggested that the large amounts of DNA in purulent secretions contribute to its viscosity and that bovine pancreatic DNase I could reduce the viscosity. To evaluate the potential clinical utility of recombinant human DNase I (rhDNase) in the treatment of cystic fibrosis, we have cloned, sequenced, and expressed rhDNase. Catalytic amounts of rhDNase greatly reduce the viscosity of purulent cystic fibrosis sputum, transforming it within minutes from a nonflowing viscous gel to a flowing liquid. The reduction in viscosity is associated with a decrease in size of DNA in the sputum. Inhalation of a rhDNase aerosol may be a simple direct approach that will help individuals with cystic fibrosis and other patients with pneumonia or bronchitis to clear their airways of purulent secretions.

Citing Articles

Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.

Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P Signal Transduct Target Ther. 2025; 10(1):75.

PMID: 40050633 PMC: 11885678. DOI: 10.1038/s41392-025-02127-9.

Physiology and pathophysiology of mucus and mucolytic use in critically ill patients.

Roe T, Talbot T, Terrington I, Johal J, Kemp I, Saeed K Crit Care. 2025; 29(1):68.

PMID: 39920835 PMC: 11806889. DOI: 10.1186/s13054-025-05286-x.

"The NET effect": Neutrophil extracellular traps-a potential key component of the dysregulated host immune response in sepsis.

Retter A, Singer M, Annane D Crit Care. 2025; 29(1):59.

PMID: 39905519 PMC: 11796136. DOI: 10.1186/s13054-025-05283-0.

Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery.

Maloney Norcross S, Levin L, Hickey A, Hill D Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770469 PMC: 11728674. DOI: 10.3390/ph17121628.

Effects of exogenous deoxyribonuclease I in collagen antibody-induced arthritis.

Macakova K, Borbelyova V, Tekelova M, Janko J, Pastorek M, Hoksa R J Inflamm (Lond). 2024; 21(1):36.

PMID: 39251994 PMC: 11386490. DOI: 10.1186/s12950-024-00403-z.

References

Boat T, Cheng P, Iyer R, CARLSON D, Polony I . Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch Biochem Biophys. 1976; 177(1):95-104. DOI: 10.1016/0003-9861(76)90419-7. View

Rommens J, Iannuzzi M, Kerem B, Drumm M, Melmer G, Dean M . Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989; 245(4922):1059-65. DOI: 10.1126/science.2772657. View

Lauffer L, Garcia P, Harkins R, Coussens L, Ullrich A, Walter P . Topology of signal recognition particle receptor in endoplasmic reticulum membrane. Nature. 1985; 318(6044):334-8. DOI: 10.1038/318334a0. View

Liao T, Salnikow J, Moore S, STEIN W . Bovine pancreatic deoxyribonuclease A. Isolation of cyanogen bromide peptides; complete covalent structure of the polypeptide chain. J Biol Chem. 1973; 248(4):1489-95. View

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

CHERNICK W, Barbero G, EICHEL H . In-vitro evaluation of effect of enzymes on tracheobronchial secretions from patients withcystic fibrosis. Pediatrics. 1961; 27:589-96. View

Smith A, Redding G, Doershuk C, Goldmann D, Gore E, Hilman B . Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr. 1988; 112(4):547-54. DOI: 10.1016/s0022-3476(88)80165-3. View

Charman J, Reid L . The effect of freezing, storing and thawing on the viscosity of sputum. Biorheology. 1973; 10(3):295-301. DOI: 10.3233/bir-1973-10302. View

POTTER J, MATTHEWS L, LEMM J, Spector S . Human pulmonary secretions in health and disease. Ann N Y Acad Sci. 1963; 106:692-7. DOI: 10.1111/j.1749-6632.1963.tb16677.x. View

10.

SPIER R, Witebsky E, PAINE J . Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections. JAMA. 1961; 178:878-86. DOI: 10.1001/jama.1961.03040480008003. View

11.

Oefner C, Suck D . Crystallographic refinement and structure of DNase I at 2 A resolution. J Mol Biol. 1986; 192(3):605-32. DOI: 10.1016/0022-2836(86)90280-9. View

12.

Funakoshi A, Tsubota Y, Wakasugi H, IBAYASHI H, Takagi Y . Purification and properties of human pancreatic deoxyribonuclease I. J Biochem. 1977; 82(6):1771-7. DOI: 10.1093/oxfordjournals.jbchem.a131875. View

13.

ELMES P, White J . Deoxyribonuclease in the treatment of purulent bronchitis. Thorax. 1953; 8(4):295-300. PMC: 1019278. DOI: 10.1136/thx.8.4.295. View

14.

ROSENTHAL A, Lacks S . Nuclease detection in SDS-polyacrylamide gel electrophoresis. Anal Biochem. 1977; 80(1):76-90. DOI: 10.1016/0003-2697(77)90627-3. View

15.

Vaudaux P, Waldvogel F . Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis. 1980; 142(4):586-93. DOI: 10.1093/infdis/142.4.586. View

16.

MATTHEWS L, Spector S, LEMM J, POTTER J . STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY. Am Rev Respir Dis. 1963; 88:199-204. DOI: 10.1164/arrd.1963.88.2.199. View

17.

KEAL E . Biochemistry and rheology of sputum in asthma. Postgrad Med J. 1971; 47(545):171-7. PMC: 2466866. DOI: 10.1136/pgmj.47.545.171. View

18.

Lieberman J . Measurement of sputum viscosity in a cone-plate viscometer. I. Characteristics of sputum viscosity. Am Rev Respir Dis. 1968; 97(4):654-61. DOI: 10.1164/arrd.1968.97.4.654. View

19.

Levy J, Smith A, Kenny M, Ramsey B, Schoenknecht F . Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum. J Infect Dis. 1983; 148(6):1069-76. DOI: 10.1093/infdis/148.6.1069. View

20.

Wood R, Boat T, DOERSHUK C . Cystic fibrosis. Am Rev Respir Dis. 1976; 113(6):833-78. DOI: 10.1164/arrd.1976.113.6.833. View